baber/WOPTO huggingface dataset:
Patent EA-004550-B1 (EA)
Title: Method for leaching copper concentrate
Inventor: HAMALAINEN MATTI
IPC: C22B15/00
Filed: 2001-12-11
Abstract: 1. A method for the leaching of sulfidic, iron-bearing copper concentrate in a chloride milieu in order to achieve an essentially iron-free, alkali chloride-copper chloride solution, and the recovery of iron and elemental sulfur as solid matter precipitate, where the leaching is carried out continuously on the countercurrent principle and in several stages, characterized in that the copper concentrate is leached in atmospheric conditions at a temperature which at highest corresponds to the boiling point of the solution, and that a longer delay is arranged for the solid matter than the solution flow-through by returning part of said solid matter to leaching contrary to the main flow of the solid matter, wherein the iron is precipitated from the concentrate mainly as hematite. 2. A method according to claim 1, characterized in that the solid matter is returned, with regard to the direction of solid matter flow, to any previous stage reactors, so that the leaching time of the solid matter is prolonged by at least twice compared with leaching time without recycling. 3. A method according to claim 2, characterized in that at the end of every stage there is liquid-solid matter separation, of which the solid matter precipitate obtained as underflow is recycled to a reactor of any previous stage. 4. A method according to claim 2, characterized in that at the end of every stage there is liquid-solid matter separation, of which the solid matter precipitate obtained as underflow is recycled to the first reactor of any previous stage. 5. A method according to claim 1, characterized in that the solid matter is returned within the same stage, with regard to the direction of solid matter flow, to the previous reactors, so that the leaching time of the solid matter is prolonged by at least twice, compared with leaching time without recycling. 6. A method according to claim 5, characterized in that at the end of every stage there is liquid-solid matter separation, of which the solid matter precipitate obtained as underflow is recycled to any reactor of the same stage. 7. A method according to claim 5, characterized in that at the end of every stage there is liquid-solid matter separation, of which the solid matter precipitate obtained as underflow is recycled to the first reactor of the same stage. 8. A method according to claim 1, characterized in that the solid matter is recycled in the single reactor. 9. A method according to claim 1, characterized in that the amount of solid matter in the first reactor of the stage is at least 250 g/L. 10. A method according to claim 1, characterized in that leaching time of the solid matter is at least 10 h.
Patent EA-010858-B1 (EA)
Title: Non-neurotoxic plasminogen activating factors for treating stroke
Inventor: SOHNGEN MARIOLA
IPC: A61P7/02
Filed: 2002-10-31
Abstract: The invention concerns the use and the production of non-neurotoxic plasminogen activating factors, derived for example from the common vampire Desmodus rotundus (DSPA), for therapeutic treatment of stroke in humans. The invention provides a novel therapeutic base for treating stroke in humans.
Patent EA-007914-B1 (EA)
Title: Dosage form of sodium ibuprofen
Inventor: GRUBER PETER
IPC: A61P29/00
Filed: 2003-10-09
Abstract: A non effervescent tablet of ibuprofen, comprising a tablet core and, if desired, a-sugar or film coat, wherein the tablet core, based on the weight of the tablet core, consists of 50 to 100% by weight sodium ibuprofen hydrate and 50 to 0% by weight auxiliary material component and contains no lubricant and no disintegrant, and wherein the sodium ibuprofen hydrate has a water content of 8 to 16% by weight, preferably 11 to 16% by weight, possesses a sufficient hardness, is comparably small and leads to a particularly rapid increase in blood level and thereby to an accelerated onset of analgesic effect. Contrary to the current doctrine sodium ibuprofen hydrate having a suitable water content is sufficiently compressible.
Patent EA-008686-B1 (EA)
Title: Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances
Inventor: FRANKE PATRICK
IPC: A61K47/14
Filed: 2004-04-21
Abstract: The invention relates to a pharmaceutical composition in the form of a hydrogel comprising a carbonic acid ester, a C-Calkyl alcohol, a active substance and a polymer matrix. The invention also relates to the use of a carbonic acid aster as a transdermal permeation agent for an active substance in a pharmaceutical composition in the form of a hydrogel, said composition comprising a polymer matrix and a C-Calkyl alcohol. The invention also relates to a perspiration-resistant composition in the form of a hydrogel, comprising an acrylic polymer combined with a cellulose derivative.
Patent EA-010716-B1 (EA)
Title: A process for maintaining a catalyst particle size distribution in a reaction system by selectively removing undesirably sized catalyst particles from a reaction system
Inventor: VAUGHN STEVEN N
IPC: B01J8/00
Filed: 2004-08-31
Abstract: The present invention provides various processes for selectively removing undesirably sized catalyst particles from a reaction system. In one embodiment, a plurality of catalyst particles, having a first median particle diameter, is withdrawn from the reaction system and is directed to a separation unit such as a counter flow cyclone separator. In the separation unit, the particles are separated into a small catalyst stream and a large catalyst stream, the small catalyst stream having a second median particle diameter less than the first median particle diameter, and the large catalyst stream having a third median particle diameter greater than the first median particle diameter. At least a portion of the small or large catalyst stream is then directed back to the reaction system in order to maintain a desirable particle size distribution therein.
Patent EA-008945-B1 (EA)
Title: Oral formulations of desoxypeganine and uses thereof
Inventor: MOORMANN JOACHIM
IPC: A61K9/00
Filed: 2004-11-08
Abstract: Orally administered film-type medicaments containing the active ingredient desoxypeganine and/or a desoxypeganine derivative, which can be used for transmucosal administration of said active ingredients.
Patent EA-013879-B1 (EA)
Title: Bonding an adherent to a substrate via a primer
Inventor: LEADLEY STUART
IPC: C09J5/02
Filed: 2006-05-10
Abstract: A method of bonding an adherent to a substrate, wherein a primer is applied to the substrate by plasma deposition and the adherent is bonded to the primer treated surface of the substrate, and the primer contains functional groups which chemically bond to functional groups in the adherent.
Patent EA-016404-B1 (EA)
Title: Improvements relating to electrolysis cells connected in series and a method for operation of same
Inventor: OVSTETUN FRANK
IPC: C25C3/16
Filed: 2008-03-10
Abstract: A method and improvements relating to an electrolysis cell, where the cell comprises a substantially horizontal cathode of an electronic conducting material and further have current leads such as horizontal collector bars embedded therein. The cell further comprises a bus bar system. The cell can be operated by improved distribution of electrical current, while said bus bar system conduct current from at least one intermediate position of the cathode. The invention can be applied for cells arranged both in an end-to-end manner and in a side-by-side manner.
Patent EA-018185-B1 (EA)
Title: Novel 1-benzyl-3-hydroxymethyilindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 or cx3cr1
Inventor: GUGLIELMOTTI ANGELO
IPC: A61K31/416
Filed: 2009-03-06
Abstract: The present invention relates to novel 1-benzyl-3-hydroxymethylindazole derivatives according to formula (I) described in the claims, and to a pharmaceutical composition comprising them, together with a pharmaceutically acceptable vehicle. In addition, the present invention relates to the use of novel 1-benzyl-3-hydroxymethylindazole derivatives for the preparation of a pharmaceutical composition that is active in the treatment of diseases based on the expression of MCP-1 and CX3CR1, and to their use in a method for treating or preventing diseases based on the expression of MCP-1 and CX3CR1.
Patent EA-022885-B1 (EA)
Title: Display device
Inventor: MUELLER-MARC OLIVER
IPC: G02F1/07
Filed: 2011-03-25
Abstract: A display device is provided, having at least one electronically actuatable display element, comprising a first liquid which comprises one non-polar component and at least one another liquid, which comprises an electrically conductive or polar liquid, wherein the first and another liquids are separated from each other and their components are not mixed with each other. Sealed volumes are filled with liquids, each of which is formed by a visible partial volume (4) and at least one holding volume (5), connected fluidically to the visible partial volume (4). When filling one of two volumes with the first liquid another volume is filled completely with the other liquid, wherein the visible partial volumes (4) are of planar design and arranged above each other along their shortest dimension. At least one voltage source is provided contacting with an electrode arrangement able to influence selectively by an electric field upon the visible partial volume for changing surface tension of the electrically conductive or polar liquid component. Wherein the dimensions of the visible partial volumes (4) are selected in such a way that a respective electrically conductive or polar liquid component in the zero-voltage state on the respective electrodes of the electrode arrangement is drawn into the respective holding volume (5) as a result of Young-Laplace pressure. The holding volumes (5) pass through those visible partial volumes (4) which are positioned further from an observer than the visible partial volume (4) with which a respective holding volume (5) communicates. The holding volume (5) which communicates with the visible partial volume (4) which is closer to the observer is designed as a glass, the symmetry axis of which passes through the symmetry point of the visible partial volume (4), and another of the rest sealed volumes is formed by the visible partial volume (4), positioned further from the observer and at least by two holding volumes (5) positioned offset from said symmetry point.
Patent EA-020030-B1 (EA)
Title: Chewing gum compositions and method of preparing same
Inventor: HUMMELUHR JENS
IPC: A23G3/00
Filed: 2009-07-07
Abstract: The present invention relates to a powdered chewing gum composition, which contains over 50% w/w chewing gum base and wherein at least 95% w/w of the particles of the composition have a particle size of less than 1200 micron in diameter. The present invention also relates to the use of said powdered chewing gum composition. The present invention also relates to a chewing gum comprising a) a core compartment, b) one or more layers comprising the composition of the present invention. The present invention further relates to a method for production of said chewing gum comprising the steps of: (a) providing a core composition; and (b) coating of the core composition with a powdered chewing gum composition by use of a panning process; and optionally (c) coating the outer intermediate layer with an outer finishing layer by use of a panning process.
Patent EA-023116-B1 (EA)
Title: Compressed dosage form produced from pharmaceutical composition containing donepezil hydrochloride of polymorphic form i, and method for producing dosage form
Inventor: SCHULZE-NAHRUP JULIA
IPC: A61P25/28
Filed: 2006-12-15
Abstract: The application describes a compressed dosage form produced by direct compression of a pharmaceutical composition which is suited for the production of compressed dosage forms and which contains 2 to 10 wt.% of donepezil hydrochloride of the polymorphic form I and microcrystalline cellulose. Donepezil hydrochloride of the polymorphic form I in the directly compressed tablet stays stable even during long storage. The application also describes a method for producing said compressed dosage form containing donepezil hydrochloride, as well as the use of donepezil hydrochloride of the polymorphic form I for producing said compressed dosage form.
Patent EA-025603-B1 (EA)
Title: Underground mining
Inventor: DELABBIO FREDRIC CHRISTOPHER
IPC: E21D9/12
Filed: 2010-06-30
Abstract: In developing an underground mine a mine shaft (80) is formed by excavating earth and removing excavated material from the shaft (80) by a material transport system comprising skips (36) movable up and down on skip guides within the shaft. Tunnels (82) are launched from a bottom part of shaft (80) by excavating a cavern (81) in which a tunnel boring machine is assembled and operated to bore the tunnels (82). Material from the tunnel excavation is transported from the tunnels via conveyor (87) to the material transport system established within the shaft during formation of the shaft which is operated to transport that material to an earth surface region.
Patent EA-023948-B1 (EA)
Title: Method for providing a low-friction surface
Inventor: ZHMUD BORIS
IPC: F16J10/04
Filed: 2010-07-16
Abstract: A manufacturing method for providing a low-friction surface comprises providing (210) of a mechanical element. A tool is mechanically rubbed (212) against a surface of the mechanical element. A process liquid is provided (214) to a contact area between the mechanical element and the tool. The process liquid comprises a first element that is a refractory metal and a second element that is a chalcogen. The first and second elements are provided in a liquid substance. The mechanical rubbing is performed with a contact pressure that is between 1 and 100% of an ultimate strength of the mechanical element. The mechanical rubbing thereby causes a combined burnishing of the surface of the mechanical element and a deposition of a tribofilm on the surface of the mechanical element. The tribofilm comprises the first element and the second element.
Patent EA-026365-B1 (EA)
Title: Housing for led lighting device
Inventor: SOKOLOV YURIY BORISOVICH
IPC: F21V15/01
Filed: 2013-07-25
Abstract: The invention relates to illumination engineering, namely to a housing for LED lighting devices designed mainly to create local and general indoor lighting. The claimed solution technical result is increase of electrical safety and production effectiveness as well as assembly simplification and lower operation costs. A LED lighting device housing contains a cavity bounded by sequentially placed walls forming a closed loop; and a joint assembly provided with means of adjacent wall mechanical connection, characterized in that the walls are made of electrically insulating material, wherein at least one of the walls has a niche adapted to house a current source and is equipped with a cover to seal it.
Patent EA-027061-B1 (EA)
Title: Use of compositions containing theobromine in treating tooth hypersensitivity
Inventor: SADEGHPOUR ARMAN
IPC: A61K6/838
Filed: 2013-03-14
Abstract: Methods for treating tooth hypersensitivity using compositions occluding a dentinal tubule within a mammalian tooth, and/or depositing a precipitate on the surface of a mammalian tooth are provided, said compositions comprising theobromine (3,7-dimethylxanthine, the principal alkaloid in Theobroma cacao).
Patent EA-032740-B1 (EA)
Title: Method for treating a tumor in a subject and kit for carrying out the method
Inventor: BRAHMBHATT HIMANSHU
IPC: A61K48/00
Filed: 2014-10-03
Abstract: The invention relates to a method for treating a tumor in a subject, comprising administering to the subject a first composition comprising a plurality of bacterially derived intact minicells or intact killed bacterial cells, each of which encompasses an anti-neoplastic agent and carries a ligand on the surface wherein the ligand has specificity to a non-phagocytic mammalian cell surface receptor, and a second composition comprising interferon-gamma (IFN-gamma) or an agent that increases the expression of IFN-gamma in the subject, and the invention also relates to a kit for carrying out said method.
Patent EA-035180-B1 (EA)
Title: Polyethylene resin and articles produced therefrom
Inventor: LELAND MARK
IPC: C07C409/22
Filed: 2015-01-30
Abstract: A polyethylene resin having a rheological breadth parameter (a parameter) of between 0.28 and 0.36, a molecular weight distribution (MWD) of between 2 and 3.5, a density of from about 0.918 to 0.950 g/cmas measured by ASTM D792, and a melt index (MI2) of from 3 to 6 at 190°C/2.16 kg as measured by ASTM D1238. The invention also relates to cast films and coatings comprising such a polyethylene resin.
Patent EA-032848-B1 (EA)
Title: Asphalt composition
Inventor: NAKAJIMA SHIGEO
IPC: C08L53/02
Filed: 2015-05-08
Abstract: An asphalt composition containing 0.5 parts by mass or more and 20 parts by mass or less of a block copolymer and 100 parts by mass of an asphalt; the block copolymer comprising a polymer block (A) mainly comprising a vinyl aromatic monomer unit, and a copolymer block (B) containing a conjugated diene monomer unit and a vinyl aromatic monomer unit; the content of the vinyl aromatic monomer unit in the block copolymer being 20% by mass or more and 60% by mass or less; the content of the polymer block (A) in the block copolymer being 10% by mass or more and 40% by mass or less; the hydrogenation rate of a double bond in the conjugated diene monomer unit of the block copolymer being 40% or more and 100% or less; the block copolymer having a peak top of a loss tangent in the range of -70°C or more and 0°C or less in a spectrum of a dynamic viscoelasticity, and a value of the peak top being 0.8 or more and 1.6 or less; and the asphalt having a colloidal index of 0.36 or more and 0.54 or less, and a saturate fraction content of 11% by mass or less.
Patent EA-036368-B1 (EA)
Title: Anti-ck8 antibodies for use in the treatment of cancers
Inventor: ALBARET MARIE ALEXANDRA
IPC: A61K39/00
Filed: 2015-08-10
Abstract: The invention relates to an antibody, an antibody fragment, a humanized antibody and an antibody fragment specifically binding human cytokeratin-8 (CK8), as well as an antigen peptide epitope for producing said antibodies and fragments thereof, the use of such antibodies or fragments thereof in the treatment of tumors whose cells express CK8 protein on their surface and pharmaceutical compositions comprising said antibodies or fragments thereof.
Patent EA-031846-B1 (EA)
Title: Device and method for discharging material on a moving substrate
Inventor: GIANNINI ANTONELLA
IPC: A24D3/02
Filed: 2015-12-01
Abstract: The present invention relates to a device for discharging particulate material, such as powder material, granules or capsules, or in general free-flowing material, such as adhesive material, on a substrate (S) moving along a conveying direction (A), comprising at least one drum rotor (R) having at least one helical track (E1, E2) carrying the material to be discharged. The drum rotor (R) is arranged adjacent to the moving substrate (S), with its axis (X) substantially parallel to said conveying direction (A) so that the portion of the at least one helical track (E1, E2) which is closest to the substrate (S) moves in the conveying direction during rotation of the drum rotor (R) and discharges the material carried thereby on the substrate (S).
Patent EA-038309-B1 (EA)
Title: Method to produce biological product to decontaminate soil and water of oil and petroleum products
Inventor: MOLDAGULOVA NAZIRA BALTABAEVNA
IPC: C12N1/20
Filed: 2017-11-22
Abstract: The invention belongs to the sphere of microbiology, biotechnology and ecology and concerns production of biological product "KazBioRem" on the basis of strains Rhodococcus erythreus AT7 and Dietzia maris 22K which may be used for bioremediation of oil-contaminated soil. Currently, oil contamination causes serious damage to natural environment. One of the ways to solve this problem is biological decontamination of oil-contaminated soils and water using microorganisms which enables fast and effective cleaning of oil-contaminated territories. Effectiveness of bioremediation of oil-contaminated soils depends directly on the presence of active strains of crude oil degraders in the medium. Well matched culture and suitable filler are the keys for development of effective biological product and successful performance of bioremediation works. Technical result is production of "KazBioRem" product on the basis of strains of crude oil degraders Rhodococcus erythreus AT7 and Dietzia maris 22K with a high titre of cells, free of cultivation in industrial fermenters.
Patent EA-037517-B1 (EA)
Title: Antiproliferative compounds, and their pharmaceutical compositions and uses
Inventor: ALEXANDER MATTHEW D
IPC: C07D417/14
Filed: 2017-01-06
Abstract: Compounds of formula A-III and B-III, pharmaceutical compositions comprising the compounds, and methods of their uses are disclosed.
Patent ES-2174741-B1 (ES)
Title: Procedimiento de disolucion de sales cristalizadas en rocas ornamentales mediante ultrasonidos.
Inventor: INIGO INIGO ADOLFO CARLOS
IPC: C04B41/53
Filed: 2000-12-22
Granted: 2004-09-16
Abstract: Procedimiento de disolución de sales cristalizadas en rocas ornamentales mediante ultrasonidos. El objetivo de la presente invención es la proposición de una alternativa a la normativa de disolución de sales cristalizadas en rocas ornamentales, Normal (1983), utilizando un método más rápido y menos tedioso. El procedimiento se realiza mediante la aplicación de un sistema de ultrasonidos, con una frecuencia de trabajo de 50 kHz, durante un tiempo al menos de 45 minutos.
Patent ES-2208034-B1 (ES)
Title: Perfeccionamientos en el objeto de la patente española n. 9950085 por "procedimiento de multiplexado para la comunicacion multimedia".
Inventor: PARK DONG SEEK
IPC: H04N7/52
Filed: 2001-11-28
Granted: 2005-05-01
Abstract: Perfeccionamientos en el objeto de la patente española n° 9950085, por "Procedimiento de multiplexado para la comunicación multimedia" que es compatible con el protocolo H.223 por medio del cambio de un cabezal de una unidad de datos de protocolo de multiplexado (MUX-PDU), que incluye las etapas de codificar datos de los media, y multiplexar los datos de los media codificados en la etapa (a) en unidades de un marco predeterminado, e introducir una segunda bandera de longitud predeterminada con una autocorrelación en el marco después de una primera bandera que presenta la apertura y el cierre del marco, con lo cual se aumenta la probabilidad de detectar la MUX-PDU por medio de un receptor mediante la adición de una bandera que presenta una alta autocorrelación al marco de la MUX-PDU del protocolo H.223, aumentando de este modo la flexibilidad respecto a errores.
Patent ES-2229831-B1 (ES)
Title: Dispositivo de proteccion personal para la apertura de correspondencia contaminada.
Inventor: CASIELLES AGUADE JOSE MARIA
IPC: B25J21/02
Filed: 2001-12-11
Granted: 2006-12-01
Abstract: Dispositivo de protección personal para la apertura de correspondencia contaminada, que consta de una bolsa y de unas manoplas, que permiten la apertura, exploración y la lectura de la correspondencia, en condiciones de completa seguridad, aún si contiene venenos químicos o agentes patógenos. De aplicación al sector de equipos de protección individual contra la contaminación.